Use of Ozempic and Similar Drugs Tripled Among Non-Diabetics, Study Shows
More Americans are turning to diabetes drugs like Ozempic, not for diabetes, but for weight loss. A new study shows that the use of GLP-1 medications among U.S. adults without diabetes more than tripled between 2018 and 2022. In that time, annual spending on these drugs surged from $1.6 billion to $5.8 billion. GLP-1 drugs,
